GlassScriptPhysician profile
Jonathan T Zoghby
NPI 1962631150
$5,511.77
in general payments reported to CMS, 2019-2025
34 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $407 · 2021: $391 · 2022: $734 · 2023: $1,113 · 2024: $944 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,445 · Entertainment: $55.49 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,444.86 |
| Entertainment | $55.49 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $746.61 | 2019-2025 | Clareon, Rocklatan, Centurion |
| Abbvie INC. | $533.35 | 2022-2025 | Vuity, Alphagan P, Lumigan |
| Mallinckrodt Hospital Products INC. | $457.25 | 2021-2025 | Acthar |
| Glaukos Corporation | $362.59 | 2019-2025 | Idosetr, Ce-Marked Kxla System, Istent Trabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $336.00 | 2019-2025 | Tecnis Iol, Tecnis Simplicity |
| Allergan, INC. | $294.15 | 2019-2021 | |
| Rxsight INC | $270.23 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Sight Sciences, INC. | $257.97 | 2019-2024 | Omni Surgical System |
| Amgen INC. | $249.90 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $224.26 | 2022-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $217.55 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Rayner Intraocular Lenses Limited | $201.95 | 2022-2024 | Omidria, Rayone Emv, Rayone Spheric |
| Novartis Pharmaceuticals Corporation | $179.62 | 2020-2023 | |
| Horizon Therapeutics Plc | $133.92 | 2022-2023 | |
| Omeros Corporation | $127.23 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $102.89 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $86.21 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $76.86 | 2024-2025 | Purified Cortrophin Gel, Iluvien |
| Thea Pharma INC. | $75.37 | 2023-2025 | Iyuzeh |
| Nova Eye, INC. | $68.44 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $63.95 | 2019-2023 | Cequa |
| Iridex Corporation | $63.39 | 2021-2023 | |
| New World Medical,INC. | $51.06 | 2025 | Via360, Streamline, Kahook Dual Blade |
| Biotissue Holdings INC. | $48.73 | 2022 | |
| Eyepoint US, INC. | $46.30 | 2019-2020 | |
| Dompe US, INC. | $38.36 | 2021-2022 | |
| Genentech USA, INC. | $38.20 | 2024-2025 | Vabysmo |
| Beaver-Visitec International, INC. | $32.49 | 2020-2021 | |
| Apellis Pharmaceuticals, INC. | $26.24 | 2023 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $25.58 | 2024 | Xdemvy |
| Ocular Therapeutix, INC. | $23.72 | 2023 | Dextenza |
| Harrow Eye, LLC | $20.57 | 2025 | Triesence |
| Halozyme INC | $18.07 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Zoghby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.